Comparison of Diclofenac suppository and Lidocaine ointment in controling episiotomy site pai
Phase 3
Recruiting
- Conditions
- Episiotomy pain control.
- Registration Number
- IRCT20220129053861N1
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
Primiparous women
Age range 18-40
Spontaneous onset of labor
Singleton pregnancy
Cephalic presentation of fetus
Mediolateral episiotomy in natural delivery
Exclusion Criteria
Postpartum hemorrhage
Use of forceps and vacuum for childbirth
Manual removal of placenta (placenta corage)
Contraindications to Nonsteroidal Anti-inflammatory drugs
Multiple perineal rupture
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sevirity of Episiotomy site pain. Timepoint: 8,16,24 hour after episiotomy and then day 3 and 7 after episiotomy. Method of measurement: Visual analogue scale.;Number of Diclofenac suppository use. Timepoint: 8,16,24 hour after episiotomy then day 3,7. Method of measurement: Record the frequency of use of medications received.;Number of Lidocaine Procaine Ointments use. Timepoint: 8,16,24 hour after episiotomy then day 3,7. Method of measurement: Record the frequency of use of lidocaine procaine ointment.
- Secondary Outcome Measures
Name Time Method Frequency of use of additional analgesic. Timepoint: Before the specified time to receive the next dose of analgesia if patient needs. Method of measurement: Record frequency of additional analgesic use.;Patient satisfaction. Timepoint: Day 3,7 after episiotomy. Method of measurement: Ask patient by phone.